Gut reaction: Study reveals opioid pain relievers with highest constipation risk

Updated on: July 09,2025 0

Gut reaction: Study reveals opioid pain relievers with highest constipation risk

Updated on:July 09,2025 0

A repurposed anti-inflammatory drug may help treat alcohol use disorder and related pain

Updated on: May 16,2025 0

A repurposed anti-inflammatory drug may help treat alcohol use disorder and related pain

Updated on:May 16,2025 0

Prostate cancer 'is not a death knell': Early detection and personalized care improve outcomes, study shows

Updated on: April 20,2025 0

Prostate cancer 'is not a death knell': Early detection and personalized care improve outcomes, study shows

Updated on:April 20,2025 0

Four-gene combo might predict lethality of stomach cancer

Updated on: May 21,2025 0

Four-gene combo might predict lethality of stomach cancer

Updated on:May 21,2025 0

Gene-edited immune cells show promise for universal 'off-the-shelf' cancer therapy

Updated on: October 05,2025 0

Gene-edited immune cells show promise for universal 'off-the-shelf' cancer therapy

Updated on:October 05,2025 0

Developing portable, blood-based device that detects colon cancer

Updated on: April 21,2025 0

Developing portable, blood-based device that detects colon cancer

Updated on:April 21,2025 0

New blood test detects tumor-derived cell-free RNA with high sensitivity

Updated on: May 20,2025 0

New blood test detects tumor-derived cell-free RNA with high sensitivity

Updated on:May 20,2025 0

A repurposed heart arrhythmia drug shows promise in killing antibiotic-resistant bacteria

Updated on: July 08,2025 0

A repurposed heart arrhythmia drug shows promise in killing antibiotic-resistant bacteria

Updated on:July 08,2025 0

Medicine Net Update 2025/07/10

On Jul 03, 2025, Norvatis announced results from the Phase III GCAptAIN study evaluating Cosentyx® (secukinumab) in adults with newly diagnosed or relapsing giant cell arteritis (GCA).

Updated on: July 16,2025 0

Medicine Net Update 2025/07/10

On Jul 03, 2025, Norvatis announced results from the Phase III GCAptAIN study evaluating Cosentyx® (secukinumab) in adults with newly diagnosed or relapsing giant cell arteritis (GCA).

Updated on:July 16,2025 0

Researchers revive decades-old pregnancy cohort with modern scientific potential

Updated on: April 18,2025 0

Researchers revive decades-old pregnancy cohort with modern scientific potential

Updated on:April 18,2025 0